Delivery Order SPE2DB24D2205-SPE2DB25FEDBY
- Not listed
- The Defense Logistics Agency awarded a $1,485.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of October 8, 2025. This non-set-aside contract was competitively awarded on September 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for osteoarthritis pain management, representing a specialized pharmaceutical product...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Zilretta 32 mg vials with a ceiling value of $9,287.25. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. Zilretta is a intra-articular corticosteroid injection used for osteoarthritis pain...
- The Defense Logistics Agency awarded a $11,144.70 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract was competitively awarded on August 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Zilretta is an intra-articular injection used for pain management in osteoarthritis, representing the type of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $3,714.90 on September 25, 2025, for the supply of Zilretta 32 mg vials, with performance completion targeted for October 17, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $3,714.90 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Zilretta 32 mg vials, with an ultimate completion date of October 1, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The product...
- The Defense Logistics Agency awarded a $3,714.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of October 7, 2025. This non-set-aside contract, awarded on September 16, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. Zilretta is a corticosteroid injection used for osteoarthritis pain management, and this order fulfills medical...
- The Defense Logistics Agency awarded a $7,429.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of October 7, 2025. This non-set-aside competitive award was issued on September 16, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,485.96 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with a firm fixed price and no set-aside designation. The order, placed under a competitive award process, is scheduled for completion by September 30, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $7,429.80 delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Zilretta 32 mg vials, with completion targeted for August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $3,714.90 to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of August 29, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. Zilretta is an intra-articular injection used for pain management in osteoarthritis, reflecting the Defense Logistics Agency's...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEDBYDelivery Order
The Defense Logistics Agency awarded a $2,228.94 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zilretta 32 mg vials, with an ultimate completion date of June 24, 2025. This non-set-aside contract was competitively awarded on June 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Zilretta is a corticosteroid injectable medication used for intra-articular injection to treat osteoarthritis pain, representing part of AmerisourceBergen's comprehensive pharmaceutical supply portfolio to federal customers. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a prime vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen supplies a broad range of pharmaceutical products and medical commodities to support military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal procurement history demonstrates its capability to fulfill competitive awards across multiple therapeutic domains and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 6/2/25 |